Squamous Cell Lung Cancer Risk Is Associated with Rare, Pathogenic Germline Variants in BRCA2 and Fanconi Anemia Genes

被引：0
|
作者：
Selvan, M. Esai
Klein, R.
Gumus, Z.
机构：
[1] Icahn Sch Med Mt Sinai, Genet & Genom, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
germline risk; Genomics; squamous lung cancer;
D O I：
10.1016/j.jtho.2019.08.1089
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.11-16
引用
收藏
页码：S522 / S522
页数：1
相关论文
共 50 条
  • [31] Targeted sequencing to discover germline variants in the BRCA1 and BRCA2 genes in a Russian population and their association with breast cancer risk
    Solodskikh, Sergei A.
    Panevina, Anna, V
    Gryaznova, Maria, V
    Gureev, Artem P.
    Serzhantova, Olga, V
    Mikhailov, Andrei A.
    Maslov, Alexander Y.
    Popov, Vasily N.
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2019, 813 : 51 - 57
  • [32] Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants
    Wen, Song
    Zhang, Meng
    Chen, Jiuan
    Hu, Li
    Sun, Jie
    Yao, Lu
    Xu, Ye
    Zhang, Juan
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (01) : 155 - 164
  • [33] Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2)
    McReynolds, Lisa J.
    Biswas, Kajal
    Giri, Neelam
    Sharan, Shyam K.
    Alter, Blanche P.
    CANCER GENETICS, 2021, 258 : 101 - 109
  • [34] BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese
    Ko, Josephine Mun-Yee
    Ning, Lvwen
    Zhao, Xue-Ke
    Chai, Annie Wai Yeeng
    Lei, Lisa Chan
    Choi, Sheyne Sta Ana
    Tao, Lihua
    Law, Simon
    Kwong, Ava
    Lee, Nikki Pui-Yue
    Chan, Kin-Tak
    Lo, Anthony
    Song, Xin
    Chen, Pei-Nan
    Chang, Yun-Li
    Wang, Li Dong
    Lung, Maria Li
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (04) : 1042 - 1051
  • [35] Emerging cancer risks in BRCA2 pathogenic germline variant carriers
    Benusiglio, Patrick R.
    Dardenne, Antoine
    Fallet, Vincent
    Cadranel, Jacques
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 (12) : 1355 - 1356
  • [36] Emerging cancer risks in BRCA2 pathogenic germline variant carriers
    Patrick R. Benusiglio
    Antoine Dardenne
    Vincent Fallet
    Jacques Cadranel
    European Journal of Human Genetics, 2023, 31 : 1355 - 1356
  • [37] Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than BRCA1 or BRCA2
    Robson, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (23) : 2528 - +
  • [38] Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
    Pal, Tuya
    Mundt, Erin
    Richardson, Marcy E.
    Chao, Elizabeth
    Pesaran, Tina
    Slavin, Thomas P.
    Couch, Fergus J.
    Monteiro, Alvaro N. A.
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [39] Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
    Pal, Tuya
    Mundt, Erin
    Richardson, Marcy
    Chao, Elizabeth
    Pesaran, Tina
    Slavin, Thomas P.
    Couch, Fergus
    Monteiro, Alvaro N.
    CANCER RESEARCH, 2024, 84 (06)
  • [40] Germline mutations in BRCA2: Shared genetic susceptibility to breast cancer, early onset leukemia and Fanconi anemia.
    Auerbach, AD
    Tolar, J
    Levran, O
    Satagopan, J
    Ben-Porat, L
    Mah, K
    Kutler, DI
    Batish, SD
    MacMillan, ML
    Hanenberg, H
    Wagner, JE
    BLOOD, 2003, 102 (11) : 23A - 23A
12345